GLOBAL ORTHOBIOLOGICS MARKET FORECAST 2017-2025
KEY FINDINGS
The orthobiologics global market is anticipated to grow from $ 6596 million in 2016 to $ 12019 million by 2025. The market is expected to grow at a CACR of 6.97% between 2017-2027. The base year considered for the market study is 2016. The forecast period is 2017-2025. Evolvement in orthobiologics has led to the development of tissue regeneration products and bone grafts that minimize hospital visits, stays and bone healing process.
MARKET INSIGHTS
The global orthobiologics market is segmented on the basis of product type, application, end-user, and geography. The global orthobiologics market by product type is segmented into the demineralized bone matrix (DBM), allograft, bone morphogenetic protein, viscosupplementation, synthetic bone graft substitutes, stem cell therapy and others. The application segment is further bifurcated into spinal fusion, trauma repair, and reconstructive surgery and others. The end-user is segmented into hospitals and clinics. The orthobiologics market by geography is classified into North America, Europe, Asia-Pacific and rest of the world. The rise in the demand for spinal fusion surgeries, development in Strategic Partnerships, and growth in Orthobiologics Material are the major drivers for the global Orthopedics market. Healthcare reforms (such as Stark self-referral law and fraud & abuse law) are estimated to have affected the Orthobiologics surgeons. Bone Regeneration Technology, Larger Spend on Healthcare is the major opportunities in the Orthobiologics Market.
REGIONAL INSIGHTS
The Orthobiologics market in North America is expected to hold the colossal share by 2024. The increase in research and a rising demand for the products, increasing research investments, aging population growth and an increased number of road accidents are major drivers of the region. Asia-Pacific is estimated with the highest CAGR of 7.09% due to the increased demand for biological implants over mechanical implants, coupled with the growing awareness levels about the benefits of Orthobiologics. Europe has generated revenue of $1705 million in 2016 and is expected to generate revenue of $3077 million by 2024. The rise in the aging population, increased incidences of osteoarthritis and osteoporosis, technological advancements in the European countries are driving the market to grow at a faster pace.
COMPETITIVE INSIGHTS
Major players for the Orthobiologics market are Bioventus, DePuy Inc. (Acquired by Johnson and Johnson), Exatech Inc., Globus Medical Inc., Integra Life sciences Holding Corporation, Johnson& Johnson, Medtronic Inc., Nuvasive Inc., RTI Surgical, Sanofi, Stryker Corporation, Zimmer Biomet Inc., and Mölnlycke Health Care AB. DePuy Inc.
The orthobiologics global market is anticipated to grow from $ 6596 million in 2016 to $ 12019 million by 2025. The market is expected to grow at a CACR of 6.97% between 2017-2027. The base year considered for the market study is 2016. The forecast period is 2017-2025. Evolvement in orthobiologics has led to the development of tissue regeneration products and bone grafts that minimize hospital visits, stays and bone healing process.
MARKET INSIGHTS
The global orthobiologics market is segmented on the basis of product type, application, end-user, and geography. The global orthobiologics market by product type is segmented into the demineralized bone matrix (DBM), allograft, bone morphogenetic protein, viscosupplementation, synthetic bone graft substitutes, stem cell therapy and others. The application segment is further bifurcated into spinal fusion, trauma repair, and reconstructive surgery and others. The end-user is segmented into hospitals and clinics. The orthobiologics market by geography is classified into North America, Europe, Asia-Pacific and rest of the world. The rise in the demand for spinal fusion surgeries, development in Strategic Partnerships, and growth in Orthobiologics Material are the major drivers for the global Orthopedics market. Healthcare reforms (such as Stark self-referral law and fraud & abuse law) are estimated to have affected the Orthobiologics surgeons. Bone Regeneration Technology, Larger Spend on Healthcare is the major opportunities in the Orthobiologics Market.
REGIONAL INSIGHTS
The Orthobiologics market in North America is expected to hold the colossal share by 2024. The increase in research and a rising demand for the products, increasing research investments, aging population growth and an increased number of road accidents are major drivers of the region. Asia-Pacific is estimated with the highest CAGR of 7.09% due to the increased demand for biological implants over mechanical implants, coupled with the growing awareness levels about the benefits of Orthobiologics. Europe has generated revenue of $1705 million in 2016 and is expected to generate revenue of $3077 million by 2024. The rise in the aging population, increased incidences of osteoarthritis and osteoporosis, technological advancements in the European countries are driving the market to grow at a faster pace.
COMPETITIVE INSIGHTS
Major players for the Orthobiologics market are Bioventus, DePuy Inc. (Acquired by Johnson and Johnson), Exatech Inc., Globus Medical Inc., Integra Life sciences Holding Corporation, Johnson& Johnson, Medtronic Inc., Nuvasive Inc., RTI Surgical, Sanofi, Stryker Corporation, Zimmer Biomet Inc., and Mölnlycke Health Care AB. DePuy Inc.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
3.1.1. ASIA-PACIFIC TO GROW AT A MAGNIFICENT RATE
3.1.2. NORTH AMERICA TO BE THE GLOBAL LEADER
3.1.3. HOSPITALS SEGMENT IS THE LARGEST REVENUE GENERATION
3.1.4. SPINAL FUSION IS THE MOST SIGNIFICANT MARKET BY APPLICATION
3.1.5. VISCOSUPPLEMENTATION GENERATED THE HIGHEST REVENUE IN TERMS OF PRODUCTS
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. DEMAND FOR SPINAL FUSION SURGERIES
4.1.2. GROWTH IN STRATEGIC PARTNERSHIPS
4.1.3. INCREASE IN ORTHOBIOLOGICS MATERIAL
4.2. RESTRAINTS
4.2.1. STRINGENT GOVERNMENT POLICIES
4.2.2. POST-SURGERY COMPLICATIONS
4.3. OPPORTUNITIES
4.3.1. BONE REGENERATION TECHNOLOGY
4.3.2. LARGER SPEND ON HEALTHCARE
4.4. CHALLENGES
4.4.1. HIGH COST OF SPINAL FUSION SURGERY
4.4.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY
4.4.3. POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE
5. SEGMENTATION
5.1. BY PRODUCTS
5.1.1. DEMINERALIZED BONE MATRIX (DBM)
5.1.2. ALLOGRAFT
5.1.3. BONE MORPHOGENETIC PROTEIN (BMP)
5.1.4. VISCOSUPPLEMENTATION
5.1.5. SYNTHETIC BONE GRAFT SUBSTITUTES
5.1.6. STEM CELL THERAPY
5.1.7. OTHERS PRODUCTS MARKET
5.2. BY APPLICATION
5.2.1. SPINAL FUSION
5.2.2. TRAUMA REPAIR
5.2.3. RECONSTRUCTIVE SURGERY
5.2.4. TENDON & LIGAMENT REPAIR MARKET
5.2.5. OTHERS APPLICATION MARKET
5.3. BY END-USER
5.3.1. HOSPITALS MARKET
5.3.2. CLINICS MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. VALUE CHAIN ANALYSIS
6.5. VENDOR LANDSCAPE
7. REGIONAL ANALYSIS
7.1. NORTH AMERICA ORTHOBIOLOGICS MARKET
7.1.1. UNITED STATES ORTHOBIOLOGICS MARKET
7.1.2. CANADA ORTHOBIOLOGICS MARKET
7.2. EUROPE ORTHOBIOLOGICS MARKET
7.2.1. UNITED KINGDOM ORTHOBIOLOGICS MARKET
7.2.2. FRANCE ORTHOBIOLOGICS MARKET
7.2.3. GERMANY ORTHOBIOLOGICS MARKET
7.2.4. SPAIN ORTHOBIOLOGICS MARKET
7.2.5. ITALY ORTHOBIOLOGICS MARKET
7.2.6. ROE ORTHOBIOLOGICS MARKET
7.3. ASIA-PACIFIC ORTHOBIOLOGICS MARKET
7.3.1. INDIA ORTHOBIOLOGICS MARKET
7.3.2. CHINA ORTHOBIOLOGICS MARKET
7.3.3. JAPAN ORTHOBIOLOGICS MARKET
7.3.4. AUSTRALIA ORTHOBIOLOGICS MARKET
7.3.5. ROAPAC ORTHOBIOLOGICS MARKET
7.4. REST OF THE WORLD ORTHOBIOLOGICS MARKET
7.4.1. LATIN AMERICA ORTHOBIOLOGICS MARKET
7.4.2. MENA ORTHOBIOLOGICS MARKET
7.4.3. AFRICA ORTHOBIOLOGICS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. MERGERS & ACQUISITIONS
9. COMPANY PROFILE
9.1. BIOVENTUS
9.1.1. OVERVIEW
9.1.2. PRODUCTS PORTFOLIO
9.1.3. STRATEGIC INITIATIVES
9.1.4. SCOT ANALYSIS
9.2. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. EXATECH INC
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. SCOT
9.3.4. STRATEGIC ANALYSIS
9.4. GLOBUS MEDICAL INC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT
9.4.5. STRATEGIC ANALYSIS
9.5. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. JOHNSON& JOHNSON
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. SWOT ANALYSIS
9.7. MEDTRONIC INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT
9.8. NUVASIVE INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. RTI SURGICAL
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.10. SANOFI
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT ANALYSIS
9.11. STRYKER CORPORATION
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. ZIMMER BIOMET INC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. STRATEGIC ANALYSIS
9.13. MÖLNLYCKE HEALTH CARE AB
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. STRATEGIC INITIATIVES
9.13.4. SCOT ANALYSIS
TABLE LIST
TABLE 1 OLDER POPULATION BY AGE GROUP: 1900 TO 2050
TABLE 2 FINANCING FOR ORTHOBIOLOGICS ADVANCEMENT
TABLE 3 POST-SURGERY COMPLICATION
TABLE 4 GLOBAL ORTHOBIOLOGICS MARKET BY PRODUCTS 2017-2025 ($ MILLIONS)
TABLE 5 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 6 ALLOGRAFT ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 7 BONE MORPHOGENETIC PROTEIN(BMP) ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 8 VISCOSUPPLEMENTATION MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 9 SYNTHETIC BONE GRAFT MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 10 STEM CELL THERAPY MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 11 OTHER PRODUCTS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 12 GLOBAL ORTHOBIOLOGICS MARKET BY APPLICATION 2017-2025 ($ MILLIONS)
TABLE 13 SPINAL FUSION MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 14 TRAUMA REPAIR MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 15 RECONSTRUCTIVE SURGERY MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 16 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 17 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 18 GLOBAL ORTHOBIOLOGICS MARKET BY END-USER , 2017-2025 ($ MILLION)
TABLE 19 HOSPITAL ORTHOBIOLOGICS MARKET, BY REGION 2017-2025 ($ MILLIONS)
TABLE 20 ORTHOBIOLOGICS CLINICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 21 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
TABLE 22 EUROPE ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
TABLE 23 EUROPE POPULATION AGE STRUCTURE BY AGE GROUP 2015
TABLE 24 ASIA-PACIFIC ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
TABLE 25 INJURIES CAUSED IN AUSTRALIA BY SPORTS IN 2015
TABLE 26 REST OF THE WORLD ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
FIGURES LIST
FIGURE 1 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 2 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 3 ALLOGRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 4 BONE MORPHOGENIC PROTEIN(BMP) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 5 VISCOSUPPLEMENTATION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 6 SYNTHETIC BONE GRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 7 STEM CELL THERAPY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 8 GLOBAL OTHER PRODUCTS MARKET 2017-2025 ($ MILLION)
FIGURE 9 SPINAL FUSION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 10 TRAUMA REPAIR ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 11 RECONSTRUCTIVE SURGERY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 12 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 13 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 14 COST OF KNEE REPLACEMENT IN DEVELOPING COUNTRIES IN 2017
FIGURE 15 ORTHOBIOLOGICS HOSPITAL MARKET 2017-2025 ($ MILLIONS)
FIGURE 16 ORTHOBIOLOGICS CLINICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 17 NORTH AMERICA POPULATION AGES 65 AND ABOVE (% OF TOTAL) BY COUNTRIES 2016
FIGURE 18 NORTH AMERICA ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025(% SHARE)
FIGURE 19 UNITED STATES (U.S.) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 20 HEALTHCARE EXPENDITURE IN THE U.S. 2014 & 2025 (% OF GDP)
FIGURE 21 CANADA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 22 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025
FIGURE 23 UNITED KINGDOM ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 24 FRANCE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 25 AGE STRUCTURE OF GERMANY 2015
FIGURE 26 GERMANY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 27 AGING POPULATION IN SPAIN 2005 AND 2015 (%)
FIGURE 28 SPAIN ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 29 ITALY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 30 ROE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 31 ASIA-PACIFIC ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025
FIGURE 32 POPULATION AGES 65 AND ABOVE IN TOP 3 COUNTRIES IN ASIA-PACIFIC (% OF TOTAL)
FIGURE 33 INDIA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 34 CHINA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 35 JAPAN ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 36 AUSTRALIA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 37 ROAPAC ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 38 REST OF THE WORLD ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
FIGURE 39 LATIN AMERICA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 40 MENA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 41 AFRICA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 42 MARKET SHARE OF ORTHOBIOLOGICS COMPANIES 2016 (%)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
3.1.1. ASIA-PACIFIC TO GROW AT A MAGNIFICENT RATE
3.1.2. NORTH AMERICA TO BE THE GLOBAL LEADER
3.1.3. HOSPITALS SEGMENT IS THE LARGEST REVENUE GENERATION
3.1.4. SPINAL FUSION IS THE MOST SIGNIFICANT MARKET BY APPLICATION
3.1.5. VISCOSUPPLEMENTATION GENERATED THE HIGHEST REVENUE IN TERMS OF PRODUCTS
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. DEMAND FOR SPINAL FUSION SURGERIES
4.1.2. GROWTH IN STRATEGIC PARTNERSHIPS
4.1.3. INCREASE IN ORTHOBIOLOGICS MATERIAL
4.2. RESTRAINTS
4.2.1. STRINGENT GOVERNMENT POLICIES
4.2.2. POST-SURGERY COMPLICATIONS
4.3. OPPORTUNITIES
4.3.1. BONE REGENERATION TECHNOLOGY
4.3.2. LARGER SPEND ON HEALTHCARE
4.4. CHALLENGES
4.4.1. HIGH COST OF SPINAL FUSION SURGERY
4.4.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY
4.4.3. POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE
5. SEGMENTATION
5.1. BY PRODUCTS
5.1.1. DEMINERALIZED BONE MATRIX (DBM)
5.1.2. ALLOGRAFT
5.1.3. BONE MORPHOGENETIC PROTEIN (BMP)
5.1.4. VISCOSUPPLEMENTATION
5.1.5. SYNTHETIC BONE GRAFT SUBSTITUTES
5.1.6. STEM CELL THERAPY
5.1.7. OTHERS PRODUCTS MARKET
5.2. BY APPLICATION
5.2.1. SPINAL FUSION
5.2.2. TRAUMA REPAIR
5.2.3. RECONSTRUCTIVE SURGERY
5.2.4. TENDON & LIGAMENT REPAIR MARKET
5.2.5. OTHERS APPLICATION MARKET
5.3. BY END-USER
5.3.1. HOSPITALS MARKET
5.3.2. CLINICS MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. VALUE CHAIN ANALYSIS
6.5. VENDOR LANDSCAPE
7. REGIONAL ANALYSIS
7.1. NORTH AMERICA ORTHOBIOLOGICS MARKET
7.1.1. UNITED STATES ORTHOBIOLOGICS MARKET
7.1.2. CANADA ORTHOBIOLOGICS MARKET
7.2. EUROPE ORTHOBIOLOGICS MARKET
7.2.1. UNITED KINGDOM ORTHOBIOLOGICS MARKET
7.2.2. FRANCE ORTHOBIOLOGICS MARKET
7.2.3. GERMANY ORTHOBIOLOGICS MARKET
7.2.4. SPAIN ORTHOBIOLOGICS MARKET
7.2.5. ITALY ORTHOBIOLOGICS MARKET
7.2.6. ROE ORTHOBIOLOGICS MARKET
7.3. ASIA-PACIFIC ORTHOBIOLOGICS MARKET
7.3.1. INDIA ORTHOBIOLOGICS MARKET
7.3.2. CHINA ORTHOBIOLOGICS MARKET
7.3.3. JAPAN ORTHOBIOLOGICS MARKET
7.3.4. AUSTRALIA ORTHOBIOLOGICS MARKET
7.3.5. ROAPAC ORTHOBIOLOGICS MARKET
7.4. REST OF THE WORLD ORTHOBIOLOGICS MARKET
7.4.1. LATIN AMERICA ORTHOBIOLOGICS MARKET
7.4.2. MENA ORTHOBIOLOGICS MARKET
7.4.3. AFRICA ORTHOBIOLOGICS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. MERGERS & ACQUISITIONS
9. COMPANY PROFILE
9.1. BIOVENTUS
9.1.1. OVERVIEW
9.1.2. PRODUCTS PORTFOLIO
9.1.3. STRATEGIC INITIATIVES
9.1.4. SCOT ANALYSIS
9.2. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. EXATECH INC
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. SCOT
9.3.4. STRATEGIC ANALYSIS
9.4. GLOBUS MEDICAL INC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT
9.4.5. STRATEGIC ANALYSIS
9.5. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. JOHNSON& JOHNSON
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. SWOT ANALYSIS
9.7. MEDTRONIC INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT
9.8. NUVASIVE INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. RTI SURGICAL
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.10. SANOFI
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT ANALYSIS
9.11. STRYKER CORPORATION
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. ZIMMER BIOMET INC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. STRATEGIC ANALYSIS
9.13. MÖLNLYCKE HEALTH CARE AB
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. STRATEGIC INITIATIVES
9.13.4. SCOT ANALYSIS
TABLE LIST
TABLE 1 OLDER POPULATION BY AGE GROUP: 1900 TO 2050
TABLE 2 FINANCING FOR ORTHOBIOLOGICS ADVANCEMENT
TABLE 3 POST-SURGERY COMPLICATION
TABLE 4 GLOBAL ORTHOBIOLOGICS MARKET BY PRODUCTS 2017-2025 ($ MILLIONS)
TABLE 5 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 6 ALLOGRAFT ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 7 BONE MORPHOGENETIC PROTEIN(BMP) ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 8 VISCOSUPPLEMENTATION MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 9 SYNTHETIC BONE GRAFT MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 10 STEM CELL THERAPY MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 11 OTHER PRODUCTS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 12 GLOBAL ORTHOBIOLOGICS MARKET BY APPLICATION 2017-2025 ($ MILLIONS)
TABLE 13 SPINAL FUSION MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 14 TRAUMA REPAIR MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 15 RECONSTRUCTIVE SURGERY MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 16 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 17 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 18 GLOBAL ORTHOBIOLOGICS MARKET BY END-USER , 2017-2025 ($ MILLION)
TABLE 19 HOSPITAL ORTHOBIOLOGICS MARKET, BY REGION 2017-2025 ($ MILLIONS)
TABLE 20 ORTHOBIOLOGICS CLINICS MARKET BY REGION 2017-2025 ($ MILLIONS)
TABLE 21 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
TABLE 22 EUROPE ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
TABLE 23 EUROPE POPULATION AGE STRUCTURE BY AGE GROUP 2015
TABLE 24 ASIA-PACIFIC ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
TABLE 25 INJURIES CAUSED IN AUSTRALIA BY SPORTS IN 2015
TABLE 26 REST OF THE WORLD ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
FIGURES LIST
FIGURE 1 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 2 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 3 ALLOGRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 4 BONE MORPHOGENIC PROTEIN(BMP) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 5 VISCOSUPPLEMENTATION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 6 SYNTHETIC BONE GRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 7 STEM CELL THERAPY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 8 GLOBAL OTHER PRODUCTS MARKET 2017-2025 ($ MILLION)
FIGURE 9 SPINAL FUSION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 10 TRAUMA REPAIR ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 11 RECONSTRUCTIVE SURGERY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 12 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 13 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 14 COST OF KNEE REPLACEMENT IN DEVELOPING COUNTRIES IN 2017
FIGURE 15 ORTHOBIOLOGICS HOSPITAL MARKET 2017-2025 ($ MILLIONS)
FIGURE 16 ORTHOBIOLOGICS CLINICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 17 NORTH AMERICA POPULATION AGES 65 AND ABOVE (% OF TOTAL) BY COUNTRIES 2016
FIGURE 18 NORTH AMERICA ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025(% SHARE)
FIGURE 19 UNITED STATES (U.S.) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 20 HEALTHCARE EXPENDITURE IN THE U.S. 2014 & 2025 (% OF GDP)
FIGURE 21 CANADA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 22 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025
FIGURE 23 UNITED KINGDOM ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 24 FRANCE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 25 AGE STRUCTURE OF GERMANY 2015
FIGURE 26 GERMANY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 27 AGING POPULATION IN SPAIN 2005 AND 2015 (%)
FIGURE 28 SPAIN ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 29 ITALY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 30 ROE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 31 ASIA-PACIFIC ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025
FIGURE 32 POPULATION AGES 65 AND ABOVE IN TOP 3 COUNTRIES IN ASIA-PACIFIC (% OF TOTAL)
FIGURE 33 INDIA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 34 CHINA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 35 JAPAN ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 36 AUSTRALIA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 37 ROAPAC ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 38 REST OF THE WORLD ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
FIGURE 39 LATIN AMERICA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 40 MENA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 41 AFRICA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 42 MARKET SHARE OF ORTHOBIOLOGICS COMPANIES 2016 (%)
